Beam Therapeutics BEAM EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's EV / sales?
- Beam Therapeutics (BEAM) reported EV / sales of 14.6× in Q1 2026.
- How has Beam Therapeutics's EV / sales changed year-over-year?
- Beam Therapeutics's EV / sales decreased by 41.4% year-over-year, from 24.9× to 14.6×.
- What is the long-term trend for Beam Therapeutics's EV / sales?
- Over 5 years (2020 to 2025), Beam Therapeutics's EV / sales has grown at a -84.7% compound annual growth rate (CAGR), from 229,503.3× to 19.1×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.